Payment overview · 2025
General Payments
$54.33
3 reported records · 1 companies
Healthcare provider profile · identity verified
Edward T Mezic, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease · OLD BRIDGE, NJ · NPI 1437218435
Verified facts
What the public records show
CMS Open Payments records show Edward T Mezic, MD received $54.33 in general payments during 2025 across 3 reported records.
Philips North America LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $54.33 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $54.33 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Vest Therapy Und Normalized: vest therapy und |
Device | Philips North America LLC | $54.33 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 690 | 94 |
| Furosemide | Furosemide | 552 | 80 |
| Levothyroxine Sodium | Levothyroxine Sodium | 533 | 66 |
| Eliquis | Apixaban | 444 | 56 |
| Amlodipine Besylate | Amlodipine Besylate | 357 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 78 |
| Potassium Chloride | Potassium Chloride | 315 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 314 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 261 | 66 |
| Mirtazapine | Mirtazapine | 248 | 19 |
| Sertraline Hcl | Sertraline Hcl | 233 | 29 |
| Simvastatin | Simvastatin | 225 | 51 |
| Losartan Potassium | Losartan Potassium | 217 | 43 |
| Metformin Hcl | Metformin Hcl | 211 | 36 |
| Donepezil Hcl | Donepezil Hcl | 210 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 190 | 33 |
| Lisinopril | Lisinopril | 183 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 173 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 166 | 43 |
| Divalproex Sodium | Divalproex Sodium | 157 | suppressed |
| Omeprazole | Omeprazole | 155 | 33 |
| Alprazolam | Alprazolam | 154 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 23 |
| Warfarin Sodium | Warfarin Sodium | 128 | suppressed |
| Finasteride | Finasteride | 124 | 12 |
| Gabapentin | Gabapentin | 124 | 26 |
| Latanoprost | Latanoprost | 124 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 119 | 12 |
| Montelukast Sodium | Montelukast Sodium | 118 | 31 |
| Metolazone | Metolazone | 117 | 14 |
| Famotidine | Famotidine | 115 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 108 | 52 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 108 | 67 |
| Spironolactone | Spironolactone | 107 | 18 |
| Allopurinol | Allopurinol | 104 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 100 | 26 |
| Breo Ellipta | Fluticasone/Vilanterol | 99 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 99 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 17 |
| Prednisone | Prednisone | 91 | 34 |
| Jardiance | Empagliflozin | 87 | 11 |
| Carvedilol | Carvedilol | 81 | 24 |
| Olanzapine | Olanzapine | 72 | suppressed |
| Clonazepam | Clonazepam | 71 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 70 | suppressed |
| Xarelto | Rivaroxaban | 70 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 68 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 68 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 12 |
| Budesonide | Budesonide | 65 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 64 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 12 |
| Lorazepam | Lorazepam | 61 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 60 | suppressed |
| Ramipril | Ramipril | 60 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 57 | 57 |
| Memantine Hcl | Memantine Hcl | 56 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 56 | 26 |
| Farxiga | Dapagliflozin Propanediol | 54 | suppressed |
| Entresto | Sacubitril/Valsartan | 53 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | suppressed |
| Bumetanide | Bumetanide | 47 | suppressed |
| Nystatin | Nystatin | 45 | 28 |
| Brimonidine Tartrate | Brimonidine Tartrate | 44 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 16 |
| Trazodone Hcl | Trazodone Hcl | 43 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 41 | suppressed |
| Bupropion Xl | Bupropion Hcl | 40 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 37 | suppressed |
| Risperidone | Risperidone | 37 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 36 | suppressed |
| Epogen | Epoetin Alfa | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 12 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 34 | 33 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Cephalexin | Cephalexin | 31 | 17 |
| Meloxicam | Meloxicam | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 21 |
| Oxcarbazepine | Oxcarbazepine | 29 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 28 | suppressed |
| Silodosin | Silodosin | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 20 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 26 | suppressed |
| Loperamide | Loperamide Hcl | 26 | suppressed |
| Oxycontin | Oxycodone Hcl | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 19 |
| Baclofen | Baclofen | 23 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 12 |
| Trintellix | Vortioxetine Hydrobromide | 23 | suppressed |
| Rytary | Carbidopa/Levodopa | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Trimethoprim | Trimethoprim | 22 | suppressed |
| Nystop | Nystatin | 21 | 15 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 11 |
| Azelastine Hcl | Azelastine Hcl | 19 | 11 |
| Cefuroxime | Cefuroxime Axetil | 19 | 14 |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 18 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 15 |
| Ondansetron Odt | Ondansetron | 17 | 15 |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Repaglinide | Repaglinide | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Tobramycin | Tobramycin | 14 | 12 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 11 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Cromolyn Sodium | Cromolyn Sodium | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Mitigare | Colchicine | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Procrit | Epoetin Alfa | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $54.33 · 3 records | Philips North America LLC | Vest Therapy Und | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error